VRDN logo

Viridian Therapeutics (VRDN) Company Overview

Profile

Full Name:

Viridian Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 18, 2014

Indexes:

Not included

Description:

Viridian Therapeutics (VRDN) is a biotechnology company focused on developing innovative treatments for serious diseases. They specialize in therapies for autoimmune and rare diseases, aiming to improve patient outcomes through advanced research and development of new medications. Their goal is to address unmet medical needs effectively.

Key Details

Price

$15.88

Annual Revenue

$314.00 K(-82.28% YoY)

Annual EPS

-$5.31(-31.11% YoY)

Annual ROE

-56.80%

Beta

1.46

Events Calendar

Earnings

Next earnings date:

Feb 27, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Feb 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 13, 2020

Analyst ratings

Recent major analysts updates

Jan 7, 25 Needham
Buy
Dec 19, 24 Wells Fargo
Equal-Weight
Dec 17, 24 RBC Capital
Outperform
Dec 17, 24 HC Wainwright & Co.
Buy
Dec 16, 24 HC Wainwright & Co.
Buy
Dec 5, 24 RBC Capital
Outperform
Nov 25, 24 TD Cowen
Buy
Nov 25, 24 Needham
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Nov 13, 24 Needham
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Viridian Therapeutics?
  • Does Viridian Therapeutics pay dividends?
  • What sector is Viridian Therapeutics in?
  • What industry is Viridian Therapeutics in?
  • What country is Viridian Therapeutics based in?
  • When did Viridian Therapeutics go public?
  • Is Viridian Therapeutics in the S&P 500?
  • Is Viridian Therapeutics in the NASDAQ 100?
  • Is Viridian Therapeutics in the Dow Jones?
  • When was Viridian Therapeutics's last earnings report?
  • When does Viridian Therapeutics report earnings?
  • Should I buy Viridian Therapeutics stock now?

What is the ticker symbol for Viridian Therapeutics?

The ticker symbol for Viridian Therapeutics is NASDAQ:VRDN

Does Viridian Therapeutics pay dividends?

No, Viridian Therapeutics does not pay dividends

What sector is Viridian Therapeutics in?

Viridian Therapeutics is in the Healthcare sector

What industry is Viridian Therapeutics in?

Viridian Therapeutics is in the Biotechnology industry

What country is Viridian Therapeutics based in?

Viridian Therapeutics is headquartered in United States

When did Viridian Therapeutics go public?

Viridian Therapeutics's initial public offering (IPO) was on June 18, 2014

Is Viridian Therapeutics in the S&P 500?

No, Viridian Therapeutics is not included in the S&P 500 index

Is Viridian Therapeutics in the NASDAQ 100?

No, Viridian Therapeutics is not included in the NASDAQ 100 index

Is Viridian Therapeutics in the Dow Jones?

No, Viridian Therapeutics is not included in the Dow Jones index

When was Viridian Therapeutics's last earnings report?

Viridian Therapeutics's most recent earnings report was on Nov 12, 2024

When does Viridian Therapeutics report earnings?

The next expected earnings date for Viridian Therapeutics is Feb 27, 2025

Should I buy Viridian Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions